Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.

Gupta A, Bisht B, Dey CS.

Neuropharmacology. 2011 May;60(6):910-20. doi: 10.1016/j.neuropharm.2011.01.033. Epub 2011 Jan 26.

PMID:
21277873
3.

Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.

Takeda S, Sato N, Rakugi H, Morishita R.

Mol Biosyst. 2011 Jun;7(6):1822-7. doi: 10.1039/c0mb00302f. Epub 2011 Mar 24. Review.

PMID:
21431241
4.

Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg.

Zimmet P, Collier G.

Drugs. 1999;58 Suppl 1:21-8; discussion 75-82. Review.

PMID:
10576521
5.
6.

Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease.

de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR.

J Alzheimers Dis. 2006 Sep;10(1):89-109. Review.

PMID:
16988486
7.

Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.

Smiley D, Umpierrez G.

Expert Opin Pharmacother. 2007 Jun;8(9):1353-64. Review.

PMID:
17563269
8.

A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus.

Seufert J, L├╝bben G, Dietrich K, Bates PC.

Clin Ther. 2004 Jun;26(6):805-18. Review.

PMID:
15262452
9.

Insulin resistance and metformin in polycystic ovary syndrome.

Ben-Haroush A, Yogev Y, Fisch B.

Eur J Obstet Gynecol Reprod Biol. 2004 Aug 10;115(2):125-33. Review.

PMID:
15262344
10.

Insulin therapy in type 2 diabetes.

Mudaliar S, Edelman SV.

Endocrinol Metab Clin North Am. 2001 Dec;30(4):935-82. Review.

PMID:
11727406
11.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
12.
13.

Metformin and pioglitazone: Effectively treating insulin resistance.

Staels B.

Curr Med Res Opin. 2006;22 Suppl 2:S27-37. Review.

PMID:
16914073
14.
15.
16.

Insulin sensitisation in the treatment of Type 2 diabetes.

Tadayyon M, Smith SA.

Expert Opin Investig Drugs. 2003 Mar;12(3):307-24. Review.

PMID:
12605557
17.

The management of insulin resistance in polycystic ovary syndrome.

Teede HJ, Hutchison SK, Zoungas S.

Trends Endocrinol Metab. 2007 Sep;18(7):273-9. Epub 2007 Aug 16. Review.

PMID:
17698366
18.

Current indications for metformin therapy.

Tankova T.

Rom J Intern Med. 2003;41(3):215-25. Review.

PMID:
15526505
19.

Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.

Mattson MP, Pedersen WA, Duan W, Culmsee C, Camandola S.

Ann N Y Acad Sci. 1999;893:154-75. Review.

PMID:
10672236
20.

Mechanisms of insulin resistance and new pharmacological approaches to metabolism and diabetic complications.

Donnelly R, Qu X.

Clin Exp Pharmacol Physiol. 1998 Feb;25(2):79-87. Review.

PMID:
9493493

Supplemental Content

Support Center